Sphingotec GmbH
Hohen Neuendorf
About Sphingotec GmbH
SphingoTec is a biomaker company that develops and markets in vitro diagnostic solutions for novel and proprietary blood-based protein biomarkers. They also develop microtiter plates, which are a standard tool in analytical research and diagnostic testing laboratories. They develop biomakers to address diagnostically underserved critical care conditions such as acute kidney injury, sepsis, and acute heart failure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Aug 2024)
- Website: sphingotec.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/sphingotec-gmbh-134898 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.